1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
North America Preimplantation Genetics Diagnosis Market Size, Share & Industry Trends Analysis Report By Test Type, By Country and Growth Forecast, 2022 – 2028

North America Preimplantation Genetics Diagnosis Market Size, Share & Industry Trends Analysis Report By Test Type, By Country and Growth Forecast, 2022 – 2028

  • April 2022
  • 58 pages
  • ID: 6283624
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The North America Preimplantation Genetics Diagnosis (PGD) Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).

PGD is widely used in in-vitro fertilization genetic testing to detect genetic problems in embryos. PGD has been shown to reduce the likelihood of generating unhealthy embryos. Furthermore, it considerably improves the odds of a healthy pregnancy. In addition, the rise in infertility rates, as well as genetic, hereditary, and chromosomal problems, boosted market expansion. Furthermore, technological improvements in PGD give benefits, such as the capacity to prevent impairment in kids and the generation of unhealthy savior siblings when PGD is combined with HLA. Furthermore, PGD showed a positive response in patients with recurrent IVF failures, low sperm count, and advanced maternal age who were trying to conceive.

In addition, it improves the odds of having a healthy pregnancy. In addition, factors such as increasing intake of alcohol, drugs, smoking, and poor food; increased stress; greater exposure to environmental contaminants; and an increase in health problems linked to hormones have all contributed to an increase in infertility cases around the world. This has increased the usage of IVF, which has had a beneficial impact on the growth of the market. Moreover, benefits such as the development of savior siblings and the increased adoption of assisted reproductive technology (ART) in underdeveloped nations are projected to boost the PGD industry. Furthermore, an increase in the risk of fatal genetic, hereditary, and chromosomal illnesses such as Duchenne muscular dystrophy, Down syndrome, cystic fibrosis, triploidy, and thalassemia encourages patients to choose PGD, thereby boosting the growth of the market.

Abnormalities, which can lead to a variety of genetic illnesses. Aneuploidy is the most common cause of Down syndrome in newborn babies in the United States, which accounts for the majority of the North American market’s income. According to a report issued by the World Health Organization in 2018, down syndrome remains the most common chromosomal abnormality, impacting 6,000 newborns born in the United States each year.

As a result, there is a strong demand for earlier detection to detect genetic problems in embryos. More income is generated by important players launching new products and a surge in improvements in healthcare infrastructure in the United States. One of the key trends in the regional market is an increase in government activities to raise public awareness and a growing preference among couples for these tests during IVF and other artificial insemination procedures.

The US market dominated the North America Preimplantation Genetics Diagnosis (PGD) Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $41.8 million by 2028. The Canada market is experiencing a CAGR of 11% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 10% during (2022 - 2028).

Based on Test Type, the market is segmented into Aneuploidy, Chromosomal Abnormalities, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, PacGenomics, CeGaT GmbH, and Laboratory Corporation of America Holdings.

Scope of the Study

Market Segments covered in the Report:

By Test Type

• Aneuploidy

• Chromosomal Abnormalities

• X-linked diseases

• Single Gene Disorders

• HLA Typing

• Gender selection

• Others

By Country

• US

• Canada

• Mexico

• Rest of North America

Companies Profiled

• Illumina, Inc.

• Invitae Corporation

• Natera, Inc.

• Agilent Technologies, Inc.

• PerkinElmer, Inc.

• Quest Diagnostics Incorporated

• Reproductive Genetic Innovations

• PacGenomics

• CeGaT GmbH

• Laboratory Corporation of America Holdings

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on